Latest News

Add to Favorites Subscribe Share
newswise-fb-share-

Showing results

110 of 532
Newswise: Oncology Pharmacists: An Essential Partner in the Cancer Journey

Article ID: 720894

Oncology Pharmacists: An Essential Partner in the Cancer Journey

Rutgers Cancer Institute of New Jersey

One of the hallmarks of a National Cancer Institute-designated Comprehensive Cancer Center is the unique oncology expertise exhibited by its clinical team, including board certified oncology pharmacists. A Rutgers Cancer Institute of New Jersey expert shares more on their role in patient care.

Released:
18-Oct-2019 8:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Comment

Article ID: 719846

Debunking Breast Cancer Myths

Rutgers Cancer Institute of New Jersey

M. Michele Blackwood, MD, FACS, chief of breast surgery at Rutgers Cancer Institute of New Jersey and medical director/Northern regional director of breast services at RWJBarnabas Health, clears up some misconceptions about breast cancer.

Released:
14-Oct-2019 7:00 AM EDT
Open in New Tab
Comment

Article ID: 719842

Can you Avoid Breast Cancer?

Rutgers Cancer Institute of New Jersey

M. Michele Blackwood, MD, FACS, chief of breast surgery at Rutgers Cancer Institute of New Jersey and medical director/Northern regional director of breast services at RWJBarnabas Health, shares expertise on breast cancer prevention and advances in breast cancer care.

Released:
7-Oct-2019 8:00 AM EDT
Open in New Tab
Comment
Newswise: Detecting Neurocognitive Change in Pediatric Cancer Patients

Article ID: 719900

Detecting Neurocognitive Change in Pediatric Cancer Patients

Rutgers Cancer Institute of New Jersey

Although cure rates for children with cancer are increasing, cancer treatments can cause permanent deterioration of brain functions leading to impairments in attention, concentration, memory and learning. With the aid of a $3.4 million NIH grant, a Rutgers Cancer Institute of New Jersey investigator and others are exploring an approach that would detect these changes among children with acute lymphoblastic leukemia early during treatment. The goal is to identify a subset of patients who would benefit from a behavioral intervention or treatment clinical trial.

Released:
1-Oct-2019 10:05 AM EDT
Open in New Tab
Comment

Article ID: 719836

Risk Factors and Screening for Breast Cancer

Rutgers Cancer Institute of New Jersey

M. Michele Blackwood, MD, FACS, chief of breast surgery at Rutgers Cancer Institute of New Jersey and medical director/Northern regional director of breast services at RWJBarnabas Health, shares expertise on breast cancer risk factors and screening.

Released:
30-Sep-2019 1:05 PM EDT
Open in New Tab
Comment
Newswise: Lumpectomy for Breast Cancer with Attention to Cosmetic Results

Article ID: 719620

Lumpectomy for Breast Cancer with Attention to Cosmetic Results

Rutgers Cancer Institute of New Jersey

As more women live with breast cancer, minimization of significant deformity in the breast after breast preservation is increasingly gaining attention. A Rutgers Cancer Institute of New Jersey surgical oncologist shares some insight.

Released:
25-Sep-2019 2:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Comment

Article ID: 719218

What is Ovarian Cancer?

Rutgers Cancer Institute of New Jersey

Ovarian Cancer is expected to impact 22,000 U.S. women this year. Rutgers Cancer Institute of New Jersey Gynecologic Oncologist Dr. Mihae Song shares some facts during this Ovarian Cancer Awareness Month.

Released:
18-Sep-2019 2:05 PM EDT
Open in New Tab
Comment

Article ID: 719223

What is Thyroid Cancer?

Rutgers Cancer Institute of New Jersey

September is Thyroid Cancer Awareness Month and Dr. Amanda Laird, Chief of Endocrine Surgery at Rutgers Cancer Institute of New Jersey shares information on types of thyroid cancer, how it is diagnosed and treatment options.

Released:
18-Sep-2019 2:05 PM EDT
Open in New Tab
Comment
Newswise: Racial Disparities in Survival Outcomes Shown in Pediatric Hodgkin Lymphoma Patients

Article ID: 719140

Racial Disparities in Survival Outcomes Shown in Pediatric Hodgkin Lymphoma Patients

Rutgers Cancer Institute of New Jersey

In what is believed to be the largest dataset study to date examining the role of race on survival outcome for pediatric patients with Hodgkin lymphoma, investigators at Rutgers Cancer Institute of New Jersey have found that black patients have significantly worse overall survival at five years than white patients when accounting for all available clinical variables.

Released:
17-Sep-2019 4:20 PM EDT
Open in New Tab
Comment

Article ID: 718298

Back to School!

Rutgers Cancer Institute of New Jersey

From maintaining regular check-ups and keeping up to date with recommended vaccinations to a good diet and exercise, some simple tips can help keep youngsters healthy as they head back to class - and are cancer preventive too.

Released:
30-Aug-2019 11:05 AM EDT
Open in New Tab
Comment

Showing results

110 of 532

Chat now!